vimarsana.com

Page 18 - நோயாளி மையமாக ஔட்கம்ஸ் ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms

NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness. The National Institutes of Health will fund a large, randomized, placebo controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19. Part of the Accelerating COVID 19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership, the ACTIV-6 trial aims to provide evidence-based treatment options for the majority of adult patients with COVID-19 who have mild-to-moderate symptoms and are not sick enough to be hospitalized. NIH will provide an initial investment of $155 million in funding for the trial.

Large clinical trial to study repurposed drugs to treat COVID-19 symptoms

Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness. The National Institutes of Health will fund a large, randomized, placebo‑controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19. Part of the Accelerating COVID‑19 Therapeutic Interventions and Vaccines (ACTIV) public–private partnership, the ACTIV-6 trial aims to provide evidence-based treatment options for the majority of adult patients with COVID-19 who have mild-to-moderate symptoms and are not sick enough to be hospitalized. NIH will provide an initial investment of $155 million in funding for the trial.

Healthy Men: Fighting for health equity year-round

Healthy Men: Fighting for health equity year-round Indigenous, Black, and Pacific Islander Americans are more than twice as likely as the general public to die from COVID-19. Written By: Armin Brott, Tribune News Service | 7:00 am, Apr. 20, 2021 × A nurse prepares a syringe of the COVID-19 vaccine on Dec. 16, 2020, in Westwood, Calif. (Los Angeles Times / TNS) April is National Minority Health Month, making it the perfect time to focus on the often-significant disparities in health and well-being that affect racial and ethnic minorities across our country. But it’s important to remember that these inequities exist every single day of the year, not just in April.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.